Overview

Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
To determine the relationship between drug plasma levels and safety, tolerability and efficacy in patients with essential tremors after dosing with Sodium oxybate
Phase:
Phase 2
Details
Lead Sponsor:
Jazz Pharmaceuticals
Treatments:
Sodium Oxybate